University of Oxford

According to the Los Angeles Times, National Institutes of Health officials are concerned about the possible side effect reported by a COVID-19 vaccine trial.

In PNAS this week: modeling of Rift Valley Fever spillover, Asian mosquito could pose malaria threat, and more.

After a pause, AstraZeneca has resumed its COVID-19 vaccine clinical trial in the UK, according to NPR.

According to Reuters, AstraZeneca has begun enrolling participants into a late-stage study of its candidate SARS-CoV-2 vaccine.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.

The New York Times reports two additional investigational vaccines appear to generate an immune response against SARS-CoV-2.

In Science this week: Fiber-seq method to examine regulatory architecture, mutations in SOST associated with osteoporosis drug-linked cardiovascular events, and more.